πŸ‡ΊπŸ‡Έ FDA
Patent

US 10201499

Nanoparticle formulation

granted A61KA61K31/19A61K47/24

Quick answer

US patent 10201499 (Nanoparticle formulation) held by United Kingdom Research and Innovation expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Kingdom Research and Innovation
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/19, A61K47/24, A61K47/28, A61K9/127